REG - MyHealthChecked PLC - Directorate Changes

MyhealthcheckedAnnouncement

11/04/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220411:nRSK8748Ha&default-theme=true

RNS Number : 8748H  MyHealthChecked PLC  11 April 2022

MyHealthChecked plc

("MyHealthChecked" or "the Company")

 

Directorate Changes

Appointment of Chief Financial Officer and Non-Executive Director changes

 

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company,
announces the appointment of Nick Edwards who will be joining the Board as
Chief Financial Officer. Nick joins MyHealthChecked on a part-time basis
immediately, taking up his position full time no later than September 2022.
Lesley Innes will also be joining the Board as a Non-Executive Director, Chair
of the Audit Committee and Company Secretary and Laura Moore has left the
Board, both with immediate effect.

 

Nick joins MyHealthChecked from Viscose Closures Limited ("Viscose"), a
manufacturer of Film and Cellulose tamper evident solutions, where he was
Finance Director for two years. Nick brings with him over 20 years' experience
having worked across multiple industries and commercial organisations,
including eight years as Group Financial controller and Analyst at BBI Group
Holdings Ltd where he worked alongside MyHealthChecked CEO, Penny McCormick.
Nick also has significant management and transactional experience, including
financial leadership for BBI's divestment from Alere Inc, and successfully
securing important bank financing and Welsh Government funding for Viscose.

 

Lesley Innes also joins the MyHealthChecked Board, with immediate effect.
Lesley is an experienced Chartered Accountant (FCA) who combines public and
private company board experience with the technical skills gained at a senior
level working at KPMG. Lesley has a significant track record of working within
quoted public companies including Wilshaw PLC, Eckoh PLC, Symphony Telecoms
Holdings PLC and more recently as non-executive director at REACT Group PLC
where she also chaired the Audit Committee and acted as Company Secretary.
Lesley also spent 14 years as Finance Director at Invigia Limited, a CRM
software company specialising in customer complaints management primarily for
the finance sector, managing the sale of the company for cash to the Equiniti
group in October 2014.

 

Laura Moore leaves the board as Non-Executive Director with immediate effect
to pursue other opportunities. Laura was appointed as a Non-Executive Director
in October 2021 following the acquisition of Nell Health.

 

Penny McCormick, Chief Executive Officer of MyHealthChecked Plc, said: "I am
delighted to be welcoming Lesley and Nick to the MyHealthChecked Board. The
last 12 months have been incredibly dynamic for the Company and as we issue
our suite of at-home wellness tests this quarter, the support and experience
brought by Nick and Lesley will be invaluable as the business continues to
grow.

 

"I would like to thank Laura for her support as we have integrated Nell Health
into the business. Laura's knowledge and industry expertise has been valued as
we continue to develop new tests and products. I wish Laura all the best and
continued success in her future endeavours."

 

Disclosures in accordance with the AIM Rules

 

Lesley Baird Innes, 64, is, or has been, a director or partner of the
following companies or partnerships during the past five years:

 

REACT Group PLC

 

Ms. Innes owns no shares in MyHealthChecked plc.

 

Nicholas Mervyn James Edwards, 51, is, or has been, a director or partner of
the following companies or partnerships during the past five years:

 

Bio-Isolates Limited

Viscose Sleeving Limited

Viscose Closures Limited

Viscose Holdings Limited

 

Mr. Edwards owns no shares in MyHealthChecked plc.

 

There are no further disclosures required in accordance with AIM Rule 17 and
Schedule Two paragraph (g) of the AIM Rules for Companies.

 

For further information contact:

 

 MyHealthChecked plc                                                www.myhealthchecked.com (http://www.myhealthchecked.com)
 Penny McCormick, Chief Executive Officer                           via Walbrook PR

 SPARK Advisory Partners Limited (NOMAD)                            Tel: +44 (0)20 3368 3550
 Neil Baldwin

 Oberon Capital Ltd (Broker)                                        Tel: +44 (0)203 179 5344
 Mike Seabrook                                                      mikeseabrook@oberoninvestments.com (mailto:mikeseabrook@oberoninvestments.com)

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
                                   (mailto:myhealthcheckedplc@walbrookpr.com)
 Paul McManus / Alice Woodings                                      Mob: +44(0)7980 541 893 / +44(0) 7407 804 654

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com
(http://www.myhealthcheckedplc.com) )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK
healthcare company focused on a range of at-home healthcare and wellness
tests.

 

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests,
now in development following the acquisition of The Genome Store in November
2020. The tests will be made available online, and would be viable for over
the counter purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in
mindset as customers become more familiar with the concept of accessible
healthcare in the growing at home testing kit market with a focus on
accessibility at the right price, led by UK-based experts.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGPUCACUPPGAU